Grown Rogue International (GRUSF) Convertible Debt (2014 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Convertible Debt of $2.8 million in Q1 2026, up 7.36% quarter-over-quarter from $2.6 million in Q4 2025, and up 139.36% on a YoY basis from $1.2 million in Q1 2025.
Grown Rogue International (GRUSF) Convertible Debt (2014 - 2026) Analysis & Trends
Grown Rogue International's Convertible Debt history runs 12 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Convertible Debt rose 139.36% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 139.36% YoY), while the FY2025 annual figure was $2.6 million, up 1031.51% from the prior year.
- Convertible Debt was $2.8 million for Q1 2026 at Grown Rogue International, up from $2.6 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $1625.2 billion in Q3 2025 to a low of $227680.0 in Q4 2024.
- Historically, Convertible Debt has averaged $125.0 billion across 5 years, with a median of $1.2 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Convertible Debt sank 60.28% in 2024, then jumped 396939409.31% in 2025.
- A 5-year view of Convertible Debt shows it stood at $1.8 million in 2022, then slumped by 67.61% to $573200.7 in 2023, then tumbled by 60.28% to $227680.0 in 2024, then surged by 1031.51% to $2.6 million in 2025, then advanced by 7.36% to $2.8 million in 2026.
- The last three Convertible Debt figures came in at $2.8 million (Q1 2026), $2.6 million (Q4 2025), and $1625.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 2.58 Mn |
| Sep 30, 2025 | 1,625.16 Bn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 227,680.00 |
| Sep 30, 2024 | 409,421.33 |
| Jun 30, 2024 | 445,212.68 |
| Mar 31, 2024 | 838,332.00 |
| Dec 31, 2023 | 573,200.67 |
| Oct 31, 2023 | 1.29 Mn |
| Jan 31, 2023 | 1.96 Mn |
| Oct 31, 2022 | 1.77 Mn |
| Oct 31, 2021 | 843,900.00 |
| Apr 30, 2021 | 311,272.00 |
| Jan 31, 2021 | 329,166.00 |
| Oct 31, 2020 | 46,099.00 |
| Jul 31, 2020 | 315,139.00 |
| Apr 30, 2020 | 50,000.00 |
| Jan 31, 2020 | 165,000.00 |